Mild Persistent Isolated Hypermethioninemia Identified through Newborn Screening in Michigan

Abstract

Methionine S-adenosyltransferase deficiency, due to mutations in MAT1A, is the most common cause of persistent isolated hypermethioninemia (PIH). While the recessive form may cause neurological consequences, the dominant form is typically benign. This condition may be found in asymptomatic infants through newborn screening programs. We describe 16 asymptomatic individuals with PIH. Our data reiterates the benign nature of PIH and reports two novel mutations in the gene. There were a disproportionate number of individuals with African descent in this cohort.

Keywords

newborn screening - persistent isolated hypermethioninemia - MAT1A mutation

• References

• 1 Cantoni GL. Activation of methionine for transmethylation. J Biol Chem 1951; 189 (02) 745-754
• 2 Chamberlin ME, Ubagai T, Mudd SH, Wilson WG, Leonard JV, Chou JY. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J Clin Invest 1996; 98 (04) 1021-1027
• 3 Couce ML, Bóveda MD, Castiñeiras DE. , et al. Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: diagnosis in an expanded neonatal screening programme. J Inherit Metab Dis 2008; 31 (Suppl. 02) S233-S239
• 4 Nagao M, Tanaka T, Furujo M. Spectrum of mutations associated with methionine adenosyltransferase I/III deficiency among individuals identified during newborn screening in Japan. Mol Genet Metab 2013; 110 (04) 460-464
• 5 Chien YH, Abdenur JE, Baronio F. , et al. Mudd's disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes. Orphanet J Rare Dis 2015; 10: 99
• 6 United State Census Bureau. Available at: https://www.census.gov/quickfacts/MI . Accessed November 26, 2018
• 7 Iacobazzi V, Infantino V, Castegna A, Andria G. Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues. Mol Genet Metab 2014; 113 (01) (02) 27-33
• 8 Chien YH, Chiang SC, Huang A, Hwu WL. Spectrum of hypermethioninemia in neonatal screening. Early Hum Dev 2005; 81 (06) 529-533
• 9 Couce ML, Bóveda MD, García-Jimémez C. , et al. Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening. Mol Genet Metab 2013; 110 (03) 218-221
• 10 Chadwick S, Fitzgerald K, Weiss B, Ficicioglu C. Thirteen patients with MAT1A mutations detected through newborn screening: 13 years' experience. JIMD Rep 2014; 14: 71-76